A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases

Gielen, 2014, The Year in Cardiology 2013: cardiovascular disease prevention, Eur Heart J, 35, 307, 10.1093/eurheartj/eht551 Lim, 2013, Cardioprotective potential of Korean Red Ginseng extract on isoproterenol-induced cardiac injury in rats, J Ginseng Res, 37, 273, 10.5142/jgr.2013.37.273 Tunstall-Pedoe, 2000, Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations, Lancet, 355, 688, 10.1016/S0140-6736(99)11181-4 Toth, 2007, Making a case for quantitative assessment of cardiovascular risk, J Clin Lipidol, 1, 234, 10.1016/j.jacl.2007.07.002 Libby, 2005, Act local, act global: inflammation and the multiplicity of “vulnerable” coronary plaques, J Am Coll Cardiol, 45, 1600, 10.1016/j.jacc.2005.02.058 Davies, 1993, The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis, J Pathol, 171, 223, 10.1002/path.1711710311 Tabas, 2007, Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications, Circulation, 116, 1832, 10.1161/CIRCULATIONAHA.106.676890 Gillis, 1997, Panax ginseng pharmacology: a nitric oxide link?, Biochem Pharmacol, 54, 1, 10.1016/S0006-2952(97)00193-7 Buettner, 2006, Systematic review of the effects of ginseng on cardiovascular risk factors, Ann Pharmacother, 40, 83, 10.1345/aph.1G216 Lim, 2013, Ginsenoside-Re ameliorates ischemia and reperfusion injury in the heart: a hemodynamics approach, J Ginseng Res, 37, 283, 10.5142/jgr.2013.37.283 Attele, 1999, Ginseng pharmacology: multiple constituents and multiple actions, Biochem Pharmacol, 58, 1685, 10.1016/S0006-2952(99)00212-9 Zhou, 2004, Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease, Med Sci Monit, 10, 187 Cheng, 2005, Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action, Acta Pharmacol Sin, 26, 143, 10.1111/j.1745-7254.2005.00034.x Nah, 2007, Ginsenosides: are any of them candidates for drugs acting on the central nervous system?, CNS Drug Rev, 13, 381 Brekhman, 1969, New substances of plant origin which increase nonspecific resistance, Annu Rev Pharmacol, 9, 419, 10.1146/annurev.pa.09.040169.002223 Bittles, 1979, The effect of ginseng on lifespan and stress responses in mice, Gerontology, 25, 125, 10.1159/000212330 Zhou, 1982, Preventive geriatrics: an overview from traditional Chinese medicine, Am J Chin Med, 10, 32, 10.1142/S0192415X82000063 Bolli, 1991, Superoxide dismutase 10 years later: a drug in search of a use, J Am Coll Cardiol, 18, 231, 10.1016/S0735-1097(10)80244-X Miller, 2009, CVT-E002 stimulates the immune system and extends the life span of mice bearing a tumor of viral origin, J Soc Integr Oncol, 7, 127 Samukawa, 2008, Protective effect of ginsenosides Rg(2) and Rh(1) on oxidation-induced impairment of erythrocyte membrane properties, Biorheology, 45, 689, 10.3233/BIR-2008-0516 Li, 2009, Regulation on energy metabolism and protection on mitochondria of Panax ginseng polysaccharide, Am J Chin Med, 37, 1139, 10.1142/S0192415X09007454 Li, 2010, An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes, J Ethnopharmacol, 130, 222, 10.1016/j.jep.2010.03.040 Sohn, 2013, A comparison of antioxidant activity of Korean White and Red Ginsengs on H2O2-induced oxidative stress in HepG2 hepatoma cells, J Ginseng Res, 37, 442, 10.5142/jgr.2013.37.442 Chen, 1996, Cardiovascular protection by ginsenosides and their nitric oxide releasing action, Clin Exp Pharmacol Physiol, 23, 728, 10.1111/j.1440-1681.1996.tb01767.x Zhou, 2005, Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries, J Vasc Surg, 41, 861, 10.1016/j.jvs.2005.01.054 Wang, 2007, Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction, J Acquir Immune Defic Syndr, 44, 493, 10.1097/QAI.0b013e3180322542 Xie, 2006, Antioxidant effects of ginsenoside Re in cardiomyocytes, Eur J Pharmacol, 532, 201, 10.1016/j.ejphar.2006.01.001 Deng, 1991, Anti-lipid peroxilative effect of ginsenoside Rb1 and Rg1, Chin Med J (Engl), 104, 395 Lü, 2009, Ginseng compounds: an update on their molecular mechanisms and medical applications, Curr Vasc Pharmacol, 7, 293, 10.2174/157016109788340767 He, 2007, Protective effects of ginsenoside Rb1 on human umbilical vein endothelial cells in vitro, J Cardiovasc Pharmacol, 50, 314, 10.1097/FJC.0b013e3180cab12e Kim, 2007, Water extract of Korean red ginseng stimulates angiogenesis by activating the Pi3k/Akt-dependent Erk1/2 and eNOS pathways in human umbilical vein endothelial cells, Biol Pharm Bull, 30, 1674, 10.1248/bpb.30.1674 Leung, 2007, Angiomodulatory and neurological effects of ginsenosides, Curr Med Chem, 14, 1371, 10.2174/092986707780597916 Nakaya, 2007, The phytoestrogen ginsensoside Re activates potassium channels of vascular smooth muscle cells through Pi3k/Akt and nitric oxide pathways, J Med Invest, 54, 381, 10.2152/jmi.54.381 Leung, 2007, Non-genomic effects of ginsenoside-Re in endothelial cells via glucocorticoid receptor, FEBS Lett, 581, 2423, 10.1016/j.febslet.2007.04.055 Papapetropoulos, 2007, A ginseng-derived oestrogen receptor beta (Erbeta) agonist, Rb1 ginsenoside, attenuates capillary morphogenesis, Br J Pharmacol, 152, 172, 10.1038/sj.bjp.0707360 Lei, 2008, Effects of extracts from Panax notoginseng and Panax ginseng fruit on vascular endothelial cell proliferation and migration in vitro, Chin J Integr Med, 14, 37, 10.1007/s11655-008-0037-0 Hong, 2009, Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo, Phytother Res, 23, 677, 10.1002/ptr.2705 Wan, 2009, Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion, J Agric Food Chem, 57, 6692, 10.1021/jf900529w Hien, 2010, Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent Pi3-kinase and Amp-activated protein kinase, Toxicol Appl Pharmacol, 246, 171, 10.1016/j.taap.2010.05.008 Jeong, 2010, Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of P38 mitogen activated protein kinase and Akt in human umbilical vein endothelial cells, Biol Pharm Bull, 33, 945, 10.1248/bpb.33.945 Furchgott, 1989, Endothelium-derived relaxing and contracting factors, FASEB J, 53, 557 Ignarro, 1989, Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein, Circ Res, 65, 1, 10.1161/01.RES.65.1.1 Moncada, 1991, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol Rev, 43, 109 Yu, 2007, Signaling pathway of nitric oxide production induced by ginsenoside Rb1 in human aortic endothelial cells: a possible involvement of androgen receptor, Biochem Biophys Res Commun, 353, 764, 10.1016/j.bbrc.2006.12.119 Leung, 2006, Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells, FEBS Lett, 580, 3211, 10.1016/j.febslet.2006.04.080 Kang, 2005, Relaxation of canine corporal smooth muscle relaxation by ginsenoside saponin Rg3 is independent from eNOS activation, Life Sci, 77, 74, 10.1016/j.lfs.2004.12.016 Jovanovski, 2010, Effects of Korean red ginseng (Panax Ginseng C.A. Mayer) and its isolated ginsenosides and polysaccharides on arterial stiffness in healthy individuals, Am J Hypertens, 23, 469, 10.1038/ajh.2010.5 Lee, 2010, Vascular smooth muscle dysfunction and remodeling induced by ginsenoside Rg3, a bioactive component of ginseng, Toxicol Sci, 117, 505, 10.1093/toxsci/kfq201 Wang, 2010, Ginsenoside Rb3 inhibits angiotensin II-induced vascular smooth muscle cells proliferation, Basic Clin Pharmacol Toxicol, 107, 685, 10.1111/j.1742-7843.2010.00560.x Rhee, 2011, Effect of Korean red ginseng on arterial stiffness in subjects with hypertension, J Altern Complement Med, 17, 45, 10.1089/acm.2010.0065 Jeon, 2000, Effect of Korea red ginseng on the blood pressure in conscious hypertensive rats, Gen Pharmacol, 35, 135, 10.1016/S0306-3623(01)00096-9 Shin, 2013, Korean red ginseng inhibits arginase and contributes to endothelium-dependent vasorelaxation through endothelial nitric oxide synthase coupling, J Ginseng Res, 37, 64, 10.5142/jgr.2013.37.64 Vuksan, 2006, Korean red ginseng (Panax ginseng) can lower blood pressure in individuals with hypertension: a randomized controlled trial, 35 Baek, 2009, Inhibition of arterial myogenic responses by a mixed aqueous extract of Salvia miltiorrhiza and Panax notoginseng (PASEL) showing antihypertensive effects, Korean J Physiol Pharmacol, 13, 287, 10.4196/kjpp.2009.13.4.287 Wagner, 1987 Liu, 2008, Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice, Planta Med, 74, 203, 10.1055/s-2008-1034303 Qin, 2008, Total ginsenosides inhibit the right ventricular hypertrophy induced by monocrotaline in rats, Biol Pharm Bull, 31, 1530, 10.1248/bpb.31.1530 Deng, 2010, Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats, Biol Pharm Bull, 33, 631, 10.1248/bpb.33.631 Wang, 2008, Ginsenoside Re suppresses electromechanical alternans in cat and human cardiomyocytes, Am J Physiol Heart Circ Physiol, 295, H851, 10.1152/ajpheart.01242.2007 Wang, 2008, Ginsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction, Cardiovasc Drugs Ther, 22, 443, 10.1007/s10557-008-6129-4 Deng, 2009, Ginsenoside Rg(1) inhibits rat left ventricular hypertrophy induced by abdominal aorta coarctation: involvement of calcineurin and mitogen-activated protein kinase signalings, Eur J Pharmacol, 608, 42, 10.1016/j.ejphar.2009.01.048 Wang, 2009, Shenfu injection suppresses apoptosis by regulation of Bcl-2 and caspase-3 during hypoxia/reoxygenation in neonatal rat cardiomyocytes in vitro, Mol Biol Rep, 36, 365, 10.1007/s11033-007-9188-x Zhu, 2009, Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis, J Cell Biochem, 108, 117, 10.1002/jcb.22233 Kim, 2010, The effects of ginseng total saponin, panaxadiol and panaxatriol on ischemia/reperfusion injury in isolated rat heart, Food Chem Toxicol, 48, 1516, 10.1016/j.fct.2010.03.018 Wu, 2011, Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats, Mol Biol Rep, 38, 4327, 10.1007/s11033-010-0558-4 Bodiga, 2011, Use of ginseng to reduce post-myocardial adverse myocardial remodeling: applying scientific principles to the use of herbal therapies, J Mol Med (Berl), 89, 317, 10.1007/s00109-011-0736-4 Guo, 2011, Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation, Circ Heart Fail, 4, 79, 10.1161/CIRCHEARTFAILURE.110.957969 Tsutsumi, 2011, a metabolite of ginsenosides, induces cardiac protection mediated nitric oxide via Akt/Pi3k pathway, Life Sci, 88, 725, 10.1016/j.lfs.2011.02.011 Zhou, 2011, Ginseng protects rodent hearts from acute myocardial ischemia-reperfusion injury through GR/ER-activated risk pathway in an endothelial NOS-dependent mechanism, J Ethnopharmacol, 135, 287, 10.1016/j.jep.2011.03.015 Tamura, 1993, Effects of Korean red ginseng on eicosanoid biosynthesis in platelets and vascular smooth muscle cells, 28 Dong-Ha Lee, 2013, Inhibitory effects of total saponin from Korean red ginseng via vasodilator-stimulated phosphoprotein-Ser157 phosphorylation on thrombin-induced platelet aggregation, J Ginseng Res, 37, 176, 10.5142/jgr.2013.37.176 Jin, 2007, Antithrombotic and antiplatelet activities of Korean red ginseng extract, Basic Clin Pharmacol Toxicol, 100, 170, 10.1111/j.1742-7843.2006.00033.x Lee, 2008, Inhibitory mechanisms of dihydroginsenoside Rg3 in platelet aggregation: critical roles of ERK2 and cAMP, J Pharm Pharmacol, 60, 1531, 10.1211/jpp.60.11.0015 Li, 2008, The protective effects of ginsenosides on human erythrocytes against hemin-induced hemolysis, Food Chem Toxicol, 46, 886, 10.1016/j.fct.2007.10.020 Yang, 2008, Improving effect of post-treatment with Panax notoginseng saponins on lipopolysaccharide-induced microcirculatory disturbance in rat mesentery, Clin Hemorheol Microcirc, 40, 119, 10.3233/CH-2008-1122 Lee, 2010, Inhibitory activity of ginsenosides isolated from processed ginseng on platelet aggregation, Pharmazie, 65, 520 Lee, 2010, Interaction between warfarin and Korean red ginseng in patients with cardiac valve replacement, Int J Cardiol, 145, 275, 10.1016/j.ijcard.2009.09.553 Yi, 2010, Total ginsenosides increase coronary perfusion flow in isolated rat hearts through activation of PI3K/Akt-eNOS signaling, Phytomedicine, 17, 1006, 10.1016/j.phymed.2010.06.012 Ahn, 2011, Red ginseng extract improves coronary flow reserve and increases absolute numbers of various circulating angiogenic cells in patients with first ST-segment elevation acute myocardial infarction, Phytother Res, 25, 239, 10.1002/ptr.3250 Trinh, 2007, Bifidus fermentation increases hypolipidemic and hypoglycemic effects of red ginseng, J Microbiol Biotechnol, 17, 1127 Hwang, 2008, Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits, Phytother Res, 22, 778, 10.1002/ptr.2363 Zhang, 2008, Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action, Clin Exp Pharmacol Physiol, 35, 1238, 10.1111/j.1440-1681.2008.04997.x Liu, 2009, Total Panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: role of downregulation of CD40 and MMP-9 expression, J Ethnopharmacol, 126, 350, 10.1016/j.jep.2009.08.014 Jia, 2010, Panax notoginseng saponins decrease cholesterol ester via up-regulating ATP-binding cassette transporter A1 in foam cells, J Ethnopharmacol, 132, 297, 10.1016/j.jep.2010.08.033 Kwak, 2010, Anti-hyperlipidemic effects of red ginseng acidic polysaccharide from Korean red ginseng, Biol Pharm Bull, 33, 468, 10.1248/bpb.33.468 Li, 2011, Ginsenoside-Rd, a purified component from Panax notoginseng saponins, prevents atherosclerosis in apoE knockout mice, Eur J Pharmacol, 652, 104, 10.1016/j.ejphar.2010.11.017 Cai, 2009, Ginsenoside-Rd, a new voltage-independent Ca2+ entry blocker, reverses basilar hypertrophic remodeling in stroke-prone renovascular hypertensive rats, Eur J Pharmacol, 606, 142, 10.1016/j.ejphar.2009.01.033 Bers, 2000, Calcium fluxes involved in control of cardiac myocyte contraction, Circ Res, 87, 275, 10.1161/01.RES.87.4.275 Chen, 2009, Effect of sugar positions in ginsenosides and their inhibitory potency on Na+/K+-ATPase activity, Acta Pharmacol Sin, 30, 61, 10.1038/aps.2008.6